Annual CFF
Summary
- Current Value
- As of today, AMRX annual cash from financing is -$211.72M, down -322.11% on
- Historical Performance
- AMRX annual cash from financing is down -53.28% over the past 3 years, and down -400.64% over the past 5 years
- All-Time High Comparison
- AMRX annual cash from financing is currently -140.61% below its historical high of $521.39M set on
- 3-Year Low Comparison
- AMRX annual cash from financing is at its 3-year low
- Sector Comparison
- AMRX annual cash from financing is higher than 8.22% of companies in Healthcare sector
Cash From Financing Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | -$211.72M | -322.1% | -53.3% | -400.6% | -2700.2% | |
| Quarterly Cash From Financing | $59.44M | +164.4% | +228.8% | +616.5% | +5221.7% | |
| TTM Cash From Financing | -$82.54M | +7.8% | +28.1% | -159.3% | -516.6% | |
| Price | $13.26 | +68.5% | +500.0% | +167.3% | – | |
| Annual Cash From Operations | $295.03M | +61.1% | +22.0% | +10000.0% | +3716.9% | |
| Annual Cash From Investing | -$63.00M | +8.9% | +67.6% | -172.4% | -189.1% | |
| Annual Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual Total Debt | $2.59B | -5.7% | -9.8% | -6.3% | +100.0% | |
| Shares Outstanding | 314.36M | +1.4% | +107.5% | +112.9% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$50.16M | -322.1% | |
| 5Y | $135.11M | N/A | -256.7% |
| All | $521.39M | -140.6% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$211.72M | at low | |
| 5Y | -$211.72M | at low | |
| All | -$211.72M | at low |
Cash From Financing History
FAQ
What is the current annual cash from financing of AMRX?
As of today, AMRX annual cash from financing is -$211.72M
What is 1-year change in AMRX annual cash from financing?
AMRX annual cash from financing is down -322.11% year-over-year
What is 3-year change in AMRX annual cash from financing?
AMRX annual cash from financing is down -53.28% over the past 3 years
How far is AMRX annual cash from financing from its all-time high?
AMRX annual cash from financing is currently -140.61% below its historical high of $521.39M set on December 1, 2015
How does AMRX annual cash from financing rank versus sector peers?
AMRX annual cash from financing is higher than 8.22% of companies in Healthcare sector
When is AMRX next annual earnings release?
The next annual earnings release for AMRX is on
Quarterly CFF
Summary
- Current Value
- As of today, AMRX quarterly cash from financing is $59.44M, up +242.59% on
- Historical Performance
- AMRX quarterly cash from financing is up +164.37% year-over-year, and up +228.85% over the past 3 years
- All-Time High Comparison
- AMRX quarterly cash from financing is currently -87.30% below its historical high of $467.98M set on
- 3-Year Low Comparison
- AMRX quarterly cash from financing is +164.37% above its 3-year low of -$92.35M reached on
- Sector Comparison
- AMRX quarterly cash from financing is higher than 92.30% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | $59.44M | +242.6% | +164.4% | +228.8% | +616.5% | |
| Annual Cash From Financing | -$211.72M | – | -322.1% | -53.3% | -400.6% | |
| TTM Cash From Financing | -$82.54M | +64.8% | +7.8% | +28.1% | -159.3% | |
| Price | $13.26 | +28.0% | +68.5% | +500.0% | +167.3% | |
| Quarterly Cash From Operations | $118.45M | +41.3% | -16.4% | +26.6% | +164.5% | |
| Quarterly Cash From Investing | -$22.46M | +15.4% | -8.5% | +54.5% | -24.2% | |
| Quarterly Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $2.69B | +4.0% | +1.6% | -6.0% | -9.3% | |
| Shares Outstanding | 314.36M | – | +1.4% | +107.5% | +112.9% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $59.44M | at high | |
| 3Y | $61.04M | -2.6% | |
| 5Y | $61.04M | -2.6% | |
| All | $467.98M | -87.3% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$61.13M | N/A | +197.2% |
| 3Y | -$92.35M | +164.4% | |
| 5Y | -$92.35M | +164.4% | |
| All | -$310.08M | +119.2% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of AMRX?
As of today, AMRX quarterly cash from financing is $59.44M
What is AMRX quarterly cash from financing most recent change?
AMRX quarterly cash from financing was up +242.59% on September 30, 2025
What is 1-year change in AMRX quarterly cash from financing?
AMRX quarterly cash from financing is up +164.37% year-over-year
How far is AMRX quarterly cash from financing from its all-time high?
AMRX quarterly cash from financing is currently -87.30% below its historical high of $467.98M set on March 31, 2020
How does AMRX quarterly cash from financing rank versus sector peers?
AMRX quarterly cash from financing is higher than 92.30% of companies in Healthcare sector
When is AMRX next earnings release?
The next earnings release for AMRX is on
TTM CFF
Summary
- Current Value
- As of today, AMRX TTM cash from financing is -$82.54M, up +64.78% on
- Historical Performance
- AMRX TTM cash from financing is up +7.82% year-over-year, and up +28.10% over the past 3 years
- All-Time High Comparison
- AMRX TTM cash from financing is currently -115.75% below its historical high of $524.24M set on
- 3-Year Low Comparison
- AMRX TTM cash from financing is +64.78% above its 3-year low of -$234.33M reached on
- Sector Comparison
- AMRX TTM cash from financing is higher than 11.96% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | -$82.54M | +64.8% | +7.8% | +28.1% | -159.3% | |
| Annual Cash From Financing | -$211.72M | – | -322.1% | -53.3% | -400.6% | |
| Quarterly Cash From Financing | $59.44M | +242.6% | +164.4% | +228.8% | +616.5% | |
| Price | $13.26 | +28.0% | +68.5% | +500.0% | +167.3% | |
| TTM Cash From Operations | $327.68M | -6.6% | +117.0% | +116.1% | +47.5% | |
| TTM Cash From Investing | -$82.87M | -2.2% | -5.4% | +66.8% | +71.8% | |
| TTM Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $2.69B | +4.0% | +1.6% | -6.0% | -9.3% | |
| Shares Outstanding | 314.36M | – | +1.4% | +107.5% | +112.9% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$82.54M | at high | |
| 3Y | -$50.16M | -64.6% | |
| 5Y | $135.11M | N/A | -161.1% |
| All | $524.24M | -115.8% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$234.33M | +64.8% | |
| 3Y | -$234.33M | +64.8% | |
| 5Y | -$359.02M | +77.0% | |
| All | -$359.02M | +77.0% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of AMRX?
As of today, AMRX TTM cash from financing is -$82.54M
What is AMRX TTM cash from financing most recent change?
AMRX TTM cash from financing was up +64.78% on September 30, 2025
What is 1-year change in AMRX TTM cash from financing?
AMRX TTM cash from financing is up +7.82% year-over-year
How far is AMRX TTM cash from financing from its all-time high?
AMRX TTM cash from financing is currently -115.75% below its historical high of $524.24M set on September 1, 2015
How does AMRX TTM cash from financing rank versus sector peers?
AMRX TTM cash from financing is higher than 11.96% of companies in Healthcare sector
When is AMRX next earnings release?
The next earnings release for AMRX is on
Cash From Financing Formula
Data Sources & References
- AMRX Official Website www.amneal.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1723128/000172312825000059/0001723128-25-000059-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1723128/000172312825000012/0001723128-25-000012-index.htm
- AMRX Profile on Yahoo Finance finance.yahoo.com/quote/AMRX
- AMRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amrx
